Source:http://linkedlifedata.com/resource/pubmed/id/10178695
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1998-6-4
|
pubmed:abstractText |
Circulating IgG-immune complexes (IgG-IC) play a role in the complex etiology of C-HUS. In an ongoing open clinical study protein A immunoadsorption treatment is carried out for patients who developed severe forms of the syndrome after mitomycin-C chemotherapy. So far, successful treatment of 14 out of 19 evaluable patients was possible. A protein A immunoadsorption system was used, allowing processing of large plasma volumes to eliminate IgG and IgG-IC from the patient's plasma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
T
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0955-3886
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19 Suppl
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
1998
|
pubmed:articleTitle |
Protein A-immunoadsorption in chemotherapy associated hemolytic-uremic syndrome.
|
pubmed:affiliation |
Department of Hematology/Oncology (Tumor-Center Hanover), Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|